Skip to content

An Observational Study Of Safety Of Sacubitril And Valsartan Combination In Patients Of HFrEF In Medicine Department Of SMS Hospital, Jaipur

An Observational Study Of Safety Of Sacubitril And Valsartan Combination In Patients Of Heart Failure With Reduced Ejection Fraction In Medicine Department Of Sawai man singh Hospital, Jaipur - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073254
Enrollment
65
Registered
2024-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: nil: nil

Sponsors

Arunkumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: pt. comming to sms

Exclusion criteria

Exclusion criteria: non cooperative

Design outcomes

Primary

MeasureTime frame
safety of drug sacubitril in indian population by serum creatinine, serum potassium, blood pressureTimepoint: at baseline, 4 weeks and 12 weeks

Secondary

MeasureTime frame
sociodemographic profileTimepoint: 0,1month,3month

Countries

India

Contacts

Public ContactDR. Arun Kumar

department of pharmacology, SMS Medical College

drJYOTSNA2003@yahoo.com09829506847

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026